Shin, C., & Holmen, S. (2015). TMOD-11 HBEGF ACTIVATES EGFR AND AXL TO FORM MALIGNANT GLIOMAS IN THE CONTEXT OF Ink4a/Arf AND Pten LOSS. Neuro Oncol.
Chicago Style CitationShin, Clifford, i Sheri Holmen. "TMOD-11 HBEGF ACTIVATES EGFR AND AXL TO FORM MALIGNANT GLIOMAS IN THE CONTEXT OF Ink4a/Arf AND Pten LOSS." Neuro Oncol 2015.
Cita MLAShin, Clifford, i Sheri Holmen. "TMOD-11 HBEGF ACTIVATES EGFR AND AXL TO FORM MALIGNANT GLIOMAS IN THE CONTEXT OF Ink4a/Arf AND Pten LOSS." Neuro Oncol 2015.
Atenció: Aquestes cites poden no estar 100% correctes.